Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]".

[This corrects the article DOI: 10.1016/j.eclinm.2021.100959.].
Epistemonikos ID: 335c8bc8e4104cb191a62d26b7ac4230b500699a
First added on: Sep 01, 2021